Founder effect of the Glu89Gln TTR mutation in the Bulgarian population-Reference-Cited by-同舟云学术

Founder effect of the Glu89Gln TTR mutation in the Bulgarian population

Published:2019-07-29 Issue:4 Volume:26 Page:181-185
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Kirov Andrey¹,Sarafov Stayko²³,Pavlova Zornitza¹⁴⁵,Todorov Tihomir¹⁴,Chamova Teodora²,Gospodinova Mariana⁶,Tournev Ivailo²⁷,Mitev Vanyo⁵,Todorova Albena¹⁴⁵

Affiliation:

1. Genetic Medico-Diagnostic Laboratory Genica, Sofia, Bulgaria;

2. Clinic of Nervous Diseases, UMBAL Aleksandrovska, Sofia, Bulgaria;

3. Department of Neurology, Medical University Sofia, Sofia, Bulgaria;

4. Genome Center “Bulgaria”, Sofia, Bulgaria;

5. Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria;

6. Clinic of Cardiology, MVR Hospital, Sofia, Bulgaria;

7. Department for Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2019.1634539

Reference23 articles.

1. Amyloid neuropathies

2. Hereditary and acquired amyloid neuropathies

3. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe

4. Guideline of transthyretin-related hereditary amyloidosis for clinicians

5. Familial Amyloid Polyneuropathy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population;International Journal of Molecular Sciences;2024-08-28

2. Genotype-Phenotype Correlations in ATTR Amyloidosis;Heart Failure Clinics;2024-07

3. Case Report: Transthyretin Glu54Leu—a rare mutation with predominant cardiac phenotype;Frontiers in Cardiovascular Medicine;2023-10-31

4. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy;European Journal of Human Genetics;2022-11-15

5. Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain;Amyloid;2022-11-07